Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators intend to validate 18F-DCFPyL test-retest reproducibility in
metastatic lesions, in order to investigate whether it serves as a reliable response
assessment tool, both to interpret existing studies and to design future longitudinal trials.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins